期刊文献+

Skp2与C-myc在食管癌中的表达及其意义

Expression and significance of Skp2 and C-myc protein in esophageal carcinoma
下载PDF
导出
摘要 目的探讨Skp2、C-myc蛋白在食管癌发生、恶性增殖及转移扩散中的作用及两者间的相互关系。方法运用免疫组织化学EnVision法检测Skp2、C-myc蛋白在97例食管癌、30例食管癌旁组织标本中的表达情况。结果Skp2与C-myc蛋白的阳性表达率在癌旁组织组(0%、0%)与食管癌组(48.45%、70.10%)、淋巴结转移阳性组(63.41%、92.68%)与淋巴结转移阴性组(37.50%、53.57%)、高分化组(29.63%、44.44%)与中分化组(53.33%、77.78%)、低分化组(60.00%、84.00%)之间差异有统计学意义(P<0.01),而与食管癌的肿瘤大小、患者、性别年龄和临床分期无关(P>0.05)。两种蛋白表达之间存在交互作用。结论Skp2和C-myc蛋白的表达与食管癌的分化程度及淋巴结的转移情况有关,分化程度低者或伴随有淋巴结转移的患者C-myc与Skp2蛋白表达增高,且两者的表达存在交互作用。 Abstract: Objective To investigate the roles of Skp2 and C-myc in the occurrence, malignant growth, proliferation and diffusion in esophageal carcinoma and the relationship between the two proteins. Methods The expressions of Skp2 protein and C-myc protein were tested by the EnVision method in 97 cases of esophageal carcinoma and 30 cases of neighboring non-cancerous tissue. Results The expression of Skp2 and C-myc proteins showed a significant difference between the esophageal carcinoma group(48.45%, 70. 10% ) and the neigh- boring non-cancerous tissue group (0%, 0% ), esophageal carcinoma with the lymph node metastasis (63.41%, 92. 68% ) and without the lymph node metastasis(37. 50%, 53.57% ), high differentiation group (29. 63%, 44.44% ) and moderate differentiation group ( 53.33% , 77.78% ) , low differentiation group (60.00%, 84.00% )( P 〈 0. 01 ). The expression of Skp2 and C-myc proteins were not correlated with tumor size, sex, age of the patients and clinical stages(P 〉0. 05), and they have interaction with each other. Conclusion The expression of Skp2 and C-myc proteins were correlated with differentiation degrees and the lymph node metastasis of esophageal carcinoma. There is interaction between the expressions of C-myc and Skp2 proteins in esophageal carcinoma.
出处 《国际内科学杂志》 CAS 2009年第3期125-127,144,F0003,共5页 International Journal of Internal Medicine
基金 河北省科学技术研究与发展指导计划项目(062761966)
关键词 SKP2蛋白 C-MYC蛋白 食管癌 Skp2 protein C-myc protein Carcinoma, esophagus
  • 相关文献

参考文献4

二级参考文献40

  • 1刘喜才,宋清斌,张灿刚,袁辉刚.ET-1, cmy-c在自体静脉移植血管内膜增殖表达意义[J].中国普通外科杂志,2005,14(7):542-543. 被引量:5
  • 2钱俊杰,孙国敬,孟祥兵,宋宜,梅柱中,刘斌,董燕,孙志贤.Skp2参与HeLa细胞G_2/M周期检查点的调控[J].中国生物化学与分子生物学报,2005,21(5):575-580. 被引量:3
  • 3Signoretti S,Di Marcotullio L,Richardson A,et al.Oncogenic role of the ublquitin ligase subunit skp2 in human breast cancer[J].J Clin Invest,2002,110(5):633 -641.
  • 4O' Hagan RC,Ohh M,David G,et al.Myc-enhanced expression of Cul1 in promotes ubiquitin-dependent proteolysis and cell cycle progression[J].Genes,2000,14 (17):2185 -2197.
  • 5Oliveira AM,Okuno SH,Nascimento AG,et al.Skp2 protein expression in soft tissue sarcomas[J].J Clin Oncol,2003,21(4):722 -727.
  • 6Korshunov A,SavostiRova M,Ozerov S.Immunohistochemical markers for prognosis of average risk pediatric medulloblastomas.The effect of apoptotic index,Trkc,and C -myc expression[J].J Neurooncol,2002,58(3):271-279.
  • 7Ganoth D,Bornstein G,Ko TK,et al.The cell-cycle regulatory protein Cks 1 is required for SCF (skp2)-mediated ubiquitinylation of p27[J].Nat Cell Biol,2001,3 (3):321 -324.
  • 8Koga H,Harada M,Ohtsubo M,et al.Troglitazone induces p27kipl -associated cell-cycle arrest through down-regulating skp2in human hepatoma cells[J].Hepatology,2003,37 (5):1086 -96.
  • 9Narayan G,Bourdon V,Chaganti S,et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer,2007,46(4) :373-384.
  • 10Chen TP, Chen CM, Chang HW, et al. Increased expression of SKP2 and phosphor-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms. Gynecol Oncol,2007,104 ( 3 ) :516-523.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部